Gene · 2050
Papers2,238
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,238
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting receptor tyrosine kinases in ovarian cancer: Genomic dysregulation, clinical evaluation of inhibitors, and potential for combinatorial therapies. | Mol Ther Oncolytics | 2023 | 36911068 | PubTator, text mining | PubMed |
| Vascular malformations: An overview of their molecular pathways, detection of mutational profiles and subsequent targets for drug therapy. | Front Neurol | 2023 | 36846125 | PubTator, text mining | PubMed |
| YULINK regulates vascular formation in zebrafish and HUVECs. | Biol Res | 2023 | 36843032 | PubTator, text mining | PubMed |
| Report of a Novel Molecular Profile in Malignant Insulinoma. | J Clin Med | 2023 | 36835815 | PubTator, text mining | PubMed |
| cRNAsp12 Web Server for the Prediction of Circular RNA Secondary Structures and Stabilities. | Int J Mol Sci | 2023 | 36835231 | PubTator, text mining | PubMed |
| CAR-Based Immunotherapy of Solid Tumours-A Survey of the Emerging Targets. | Cancers (Basel) | 2023 | 36831514 | PubTator, text mining | PubMed |
| Eph Receptors in Cancer. | Biomedicines | 2023 | 36830852 | PubTator, text mining | PubMed |
| Identification of MET fusions as novel therapeutic targets sensitive to MET inhibitors in lung cancer. | J Transl Med | 2023 | 36829199 | PubTator, text mining | PubMed |
| Seven cases of hereditary haemorrhagic telangiectasia-like hepatic vascular abnormalities associated with EPHB4 pathogenic variants. | J Med Genet | 2023 | 36813543 | PubTator, text mining | PubMed |
| Hereditary Hemorrhagic Telangiectasia in Pediatric Age: Focus on Genetics and Diagnosis. | Pediatr Rep | 2023 | 36810341 | PubTator, text mining | PubMed |
| Response and acquired resistance to MET inhibitors in de novo MET fusion-positive advanced non-small cell lung cancer. | Lung Cancer | 2023 | 36806896 | PubTator, text mining | PubMed |
| Optimization of the Lead Compound NVP-BHG712 as a Colorectal Cancer Inhibitor. | Chemistry | 2023 | 36799129 | PubTator, text mining | PubMed |
| When three is not a crowd: trispecific antibodies for enhanced cancer immunotherapy. | Theranostics | 2023 | 36793863 | PubTator, text mining | PubMed |
| Microphysiological model of PIK3CA-driven vascular malformations reveals a role of dysregulated Rac1 and mTORC1/2 in lesion formation. | Sci Adv | 2023 | 36791204 | PubTator, text mining | PubMed |
| Identification of potential biomarkers and immune infiltration characteristics in recurrent implantation failure using bioinformatics analysis. | Front Immunol | 2023 | 36776897 | PubTator, text mining | PubMed |
| The EPH/Ephrin System in Pancreatic Ductal Adenocarcinoma (PDAC): From Pathogenesis to Treatment. | Int J Mol Sci | 2023 | 36769332 | PubTator, text mining | PubMed |
| Systemically Identifying Triple-Negative Breast Cancer Subtype-Specific Prognosis Signatures, Based on Single-Cell RNA-Seq Data. | Cells | 2023 | 36766710 | PubTator, text mining | PubMed |
| Exploiting the Stemness and Chemoresistance Transcriptome of Ewing Sarcoma to Identify Candidate Therapeutic Targets and Drug-Repurposing Candidates. | Cancers (Basel) | 2023 | 36765727 | PubTator, text mining | PubMed |
| Reclassification of the Etiology of Infant Mortality With Whole-Genome Sequencing. | JAMA Netw Open | 2023 | 36757698 | PubTator, text mining | PubMed |
| Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | Mol Cell | 2023 | 36736316 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2050/papers?page=16